EyePoint Pharmaceuticals Inc - Chess Depository Interest


By |


EyePoint Pharmaceuticals Inc is a US-based specialty pharmaceutical company which is engaged in developing sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. The company has developed three sustained-release products for the treatment of back-of-the-eye diseases. The lead product candidate is Durasert which is designed to treat chronic non-infectious uveitis affecting the posterior segment of the eye for three years from a single injection. The company's development program is focused primarily on utilizing two core technology platforms to deliver drugs and biologics to treat chronic diseases.

Contact Information

Website: www.eyepointpharma.com
Email: Info@psivida.com
Main Phone: +1 617 926-5000
Address: 480 Pleasant Street
Address 2: Suite B300
State: MA
City / Town: Watertown
Country: USA
Postal Code: 02472

Issuer Information

Exchange: GREY
CEO: Nancy Lurker
Employees: 44
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.99 $ 0. (0.00%)
Last Price 1.99 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 1.99
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap 188.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 94,855,705.00 EPS (TTM) -1.44 PE Ratio N/A Exchange Greys
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Leonard S. Ross 1,000
Leonard S. Ross 1,000
Paul Ashton 1,000
Leonard S. Ross 1,000
Leonard S. Ross 1,000